Clinical profile and metabolic and hormonal variables of the PCOS and control groups.</p
<p>*P<0.001 compared to control group. Data are median (interquartile range). In the replication coh...
<p>Clinical parameters and the genotype of the patients involved in the study.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
Clinical profile and metabolic and hormonal variables of the PCOS and control groups.</p
Clinical, hormonal and metabolic characteristics of women with PCOS versus controls.</p
<p>Clinical and biochemical characteristics of women with PCOS and control subjects.</p
<p><i>Abbreviations</i> DHEAS, dehydroepiandrosterone-sulfate; HDL, high-density lipoprotein; LDL, l...
Characteristics of PCOS cases and controls from each cohort included in the meta-analysis.</p
Summary of characteristics that matched those with HDP or GDM to their respective control groups.</p
<p>Clinical and biochemical characteristics of controls and hypertriglyceridemic patients.</p
a<p>p<0.01.</p>b<p>p<0.001 compared to healthy controls.</p>c<p>p<0.01.</p>d<p>p<0.001 compared to N...
General, anthropometric, body composition and metabolic characteristics of the PD and control groups...
Sociodemographic, biochemical, blood pressure and body composition data as a function of group.</p
<p>Clinical and demographic profile of patients as per the etiologic subgroups.</p
<p>Statistical differences between groups were compared with independent sample <i>t</i>-tests or AN...
<p>*P<0.001 compared to control group. Data are median (interquartile range). In the replication coh...
<p>Clinical parameters and the genotype of the patients involved in the study.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
Clinical profile and metabolic and hormonal variables of the PCOS and control groups.</p
Clinical, hormonal and metabolic characteristics of women with PCOS versus controls.</p
<p>Clinical and biochemical characteristics of women with PCOS and control subjects.</p
<p><i>Abbreviations</i> DHEAS, dehydroepiandrosterone-sulfate; HDL, high-density lipoprotein; LDL, l...
Characteristics of PCOS cases and controls from each cohort included in the meta-analysis.</p
Summary of characteristics that matched those with HDP or GDM to their respective control groups.</p
<p>Clinical and biochemical characteristics of controls and hypertriglyceridemic patients.</p
a<p>p<0.01.</p>b<p>p<0.001 compared to healthy controls.</p>c<p>p<0.01.</p>d<p>p<0.001 compared to N...
General, anthropometric, body composition and metabolic characteristics of the PD and control groups...
Sociodemographic, biochemical, blood pressure and body composition data as a function of group.</p
<p>Clinical and demographic profile of patients as per the etiologic subgroups.</p
<p>Statistical differences between groups were compared with independent sample <i>t</i>-tests or AN...
<p>*P<0.001 compared to control group. Data are median (interquartile range). In the replication coh...
<p>Clinical parameters and the genotype of the patients involved in the study.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p